DiscoverRx for BiotechThe Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

Update: 2025-03-02
Share

Description

In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative dendritic cell vaccine therapy designed to tackle some of the most challenging cancers, including glioblastoma and pancreatic cancer
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

Podcast Host Chris Leidli